Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00096109
Status:
TERMINATED
Last Update Posted:
2017-01-16
First Post:
2004-11-09
Brief Title:
Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Breast Cancer |
| Recurrent Breast Cancer |
| Stage IIIB Breast Cancer |
| Stage IIIC Breast Cancer |
Keywords: